[Federal Register Volume 76, Number 70 (Tuesday, April 12, 2011)]
[Notices]
[Pages 20352-20353]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-8653]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Notice of Intent To Award Affordable Care Act (ACA) Funding
Notice of Intent to award Affordable Care Act (ACA) funding to two
Emerging Infections Program (EIP) grantees, the Connecticut Department
of Public Health and the Georgia Department of Community Health, to
increase support for vaccine effectiveness activities for rotavirus
vaccine and pneumococcal conjugate vaccine. These activities were
proposed in the grantees' Fiscal Year (FY) 2011 non-competitive
continuation applications under funding opportunity CI05-026,
``Emerging Infections Program (EIP).''
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice provides public announcement of CDC's intent to
award Affordable Care Act (ACA) appropriations to the Connecticut
Department of Public Health and the Georgia Department of Community
Health to conduct vaccine effectiveness activities for rotavirus
vaccine and 13-valent pneumococcal conjugate vaccine (PCV). These
activities were requested by the two grantees in their FY 2011 non-
competitive continuation applications submitted under funding
opportunity CI05-026, ``Emerging Infections Program (EIP),'' Catalogue
of Federal Domestic Assistance Number (CFDA): 93.283. Due to a lack of
funding availability, these activities were either approved but
unfunded or only partially funded in the grantee's FY 2011 continuation
award.
Only these two EIP sites requested funding for the rotavirus
activities and only one site (Georgia) requested funding for the PCV
activities. Since no other EIP sites requested funding for these
specific activities, Connecticut and Georgia will be the only sites
receiving funding for these activities.
Approximately $433,500 in ACA funding will be awarded, which
includes $333,500 for Rotavirus and $100,000 for PCV, to increase the
amount of funding available to evaluate the effectiveness of new
rotavirus and PCV vaccines currently being monitored through the
aforementioned participating EIP sites. Funding is appropriated under
the Affordable Care Act (PL 111-148), Title IV, Section 4002
(Prevention and Public Health Fund).
Accordingly, CDC adds the following information to the previously
published funding opportunity announcement:
--Authority: Affordable Care Act (Pub. L. 111-148), Title IV, Section
4002 (Prevention and Public Health Fund).
--CFDA #: 93.521--CDC--Investigations, Technical Assistance and
Affordable Care Act Projects.
Award Information:
Type of Award: Supplement to existing cooperative agreement.
Approximate Total Current Fiscal Year ACA Funding: $433,500.
Rotavirus (CT & GA): $333,500.
PCV (GA only): $100,000.
Anticipated Number of Awards: 2.
Fiscal Year Funds: 2011.
Anticipated Award Date: June 2011.
Application Selection Process:
Funding will be awarded to only those sites that included proposals
for the specific rotavirus and PCV vaccine effectiveness activities in
their EIP FY 2011 continuation application.
Funding Authority:
CDC will add the ACA Authority to that which is reflected in the
published Funding Opportunity CDC-RFA-CI05-026. The revised funding
authority language will read:
--This program is authorized under the Public Health Service Act
Sections 301(a)[42 U.S.C. 241(a)], 317(k)(1)[42 U.S.C. 247b(k)(1)], and
317(k)(2)[42 U.S.C. 247b(k)(2)], as amended, and Affordable Care Act
(Pub. L. 111-148), Title IV, Section 4002 (Prevention and Public Health
Fund).
DATES: The effective date for this action is the date of publication of
this Notice and remains in effect until the expiration of the project
period of the ACA funded applications.
FOR FURTHER INFORMATION CONTACT: Elmira Benson, Acting Deputy Director,
Centers for Disease Control and Prevention, 2920 Brandywine Road,
Atlanta, GA 30341, telephone (770) 488-2802, e-mail
[email protected].
SUPPLEMENTARY INFORMATION: On March 23, 2010, the President signed into
law the Affordable Care Act (ACA), Public Law 111-148. ACA is designed
to improve and expand the scope of health care coverage for Americans.
Cost savings through disease prevention is an
[[Page 20353]]
important element of this legislation and ACA has established a
Prevention and Public Health Fund (PPHF) for this purpose.
Specifically, the legislation states in Section 4002 that the PPHF is
to ``provide for expanded and sustained national investment in
prevention and public health programs to improve health and help
restrain the rate of growth in private and public sector health care
costs.'' ACA and the Prevention and Public Health Fund make improving
public health a priority with investments to improve public health.
The PPHF states that the Secretary shall transfer amounts in the
Fund to accounts within the Department of Health and Human Services to
increase funding, over the fiscal year 2008 level, for programs
authorized by the Public Health Service Act, for prevention, wellness
and public health activities including prevention research and health
screenings, such as the Community Transformation Grant Program, the
Education and Outreach Campaign for Preventative Benefits, and
Immunization Programs.
ACA legislation affords an important opportunity to advance public
health across the lifespan and to reduce health disparities by
supporting an intensive community approach to chronic disease
prevention and control. Therefore, increasing funding available to
applicants under this FOA using the PPHF to continue monitoring the
effectiveness of vaccines is consistent with the purpose of the PPHF,
as stated above, to provide for an expanded and sustained national
investment in prevention and public health programs. Further, the
Secretary allocated funds to CDC, pursuant to the PPHF, for the types
of activities this FOA is designed to carry out.
Dated: March 25, 2011.
Tanja Popovic,
Deputy Associate Director for Science, Centers for Disease Control and
Prevention.
[FR Doc. 2011-8653 Filed 4-11-11; 8:45 am]
BILLING CODE 4163-18-P